Detalhe da pesquisa
1.
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
N Engl J Med;
388(26): 2434-2443, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37199451
2.
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
MMWR Morb Mortal Wkly Rep;
73(16): 377-381, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38662708
3.
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.
MMWR Morb Mortal Wkly Rep;
72(24): 657-662, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37319020
4.
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep;
72(41): 1115-1122, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37824423
5.
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
MMWR Morb Mortal Wkly Rep;
72(42): 1140-1146, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37856366
6.
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
MMWR Morb Mortal Wkly Rep;
72(20): 553-558, 2023 May 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37200229
7.
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
MMWR Morb Mortal Wkly Rep;
71(45): 1436-1441, 2022 Nov 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36355612
8.
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022.
MMWR Morb Mortal Wkly Rep;
71(31): 988-992, 2022 Aug 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35925807
9.
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
MMWR Morb Mortal Wkly Rep;
71(26): 859-868, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35771731
10.
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022.
MMWR Morb Mortal Wkly Rep;
71(11): 416-421, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35298454
11.
Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021.
MMWR Morb Mortal Wkly Rep;
70(5): 174-177, 2021 Feb 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33539333
12.
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.
MMWR Morb Mortal Wkly Rep;
70(20): 749-752, 2021 May 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34014913
13.
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
MMWR Morb Mortal Wkly Rep;
70(45): 1579-1583, 2021 Nov 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34758012
14.
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
MMWR Morb Mortal Wkly Rep;
70(38): 1344-1348, 2021 Sep 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34555007
15.
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
MMWR Morb Mortal Wkly Rep;
70(17): 651-656, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33914723
16.
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
MMWR Morb Mortal Wkly Rep;
70(44): 1545-1552, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34735422
17.
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
MMWR Morb Mortal Wkly Rep;
70(27): 977-982, 2021 Jul 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34237049
18.
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
MMWR Morb Mortal Wkly Rep;
70(32): 1094-1099, 2021 Aug 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34383735
19.
Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.
MMWR Morb Mortal Wkly Rep;
69(14): 419-421, 2020 Apr 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32271724
20.
Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury - United States, October 2019.
MMWR Morb Mortal Wkly Rep;
68(41): 919-927, 2019 10 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31633675